<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Monitoring neuromuscular blockade</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Monitoring neuromuscular blockade</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Monitoring neuromuscular blockade</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Johnathan Ross Renew, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Girish P Joshi, MB, BS, MD, FFARCSI</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marianna Crowley, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 11, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1734342045"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Neuromuscular blocking agents (NMBAs) are usually administered during anesthesia to facilitate endotracheal intubation and/or to improve surgical conditions. Neuromuscular block should be monitored for all patients who receive NMBAs during anesthesia, to guide dosing of NMBAs and reversal agents, and to assess the degree of recovery.</p><p>This topic will discuss the devices that may be used, the patterns of nerve stimulation, and interpretation of results. The choice of NMBAs, clinical uses for anesthesia, and reversal of neuromuscular block are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia"</a>.)</p><p class="headingAnchor" id="H39711368"><span class="h1">WHEN AND HOW TO MONITOR NEUROMUSCULAR BLOCKADE</span><span class="headingEndMark"> — </span>We suggest the use of quantitative, objective measurement of neuromuscular function (ie, accelerometry, electromyography [EMG], kinemyography [KMG]) to monitor administration of and recovery from neuromuscular blocking agents (NMBAs) whenever possible. If a quantitative monitor is not available, qualitative monitoring with a peripheral nerve stimulator may be used, but only to determine the depth of block (train-of-four count [TOFC]). Evaluations of train-of-four (TOF) fade made subjectively (with a peripheral nerve stimulator) <strong>cannot</strong> assure adequate recovery. (See <a class="local">'Qualitative versus quantitative monitoring'</a> below.)</p><p>In 2023, both the American Society of Anesthesiologists (ASA) and European Society of Anaesthesiology and Intensive Care (ESAIC) published guidelines on the management of neuromuscular blockade [<a href="#rid1">1,2</a>]. Both societies strongly recommend the use of objective monitors whenever NMBAs are administered. A summary of the ASA recommendations is shown in a table  (<a class="graphic graphic_table graphicRef140502" href="/z/d/graphic/140502.html" rel="external">table 1</a>). These recommendations align with a consensus statement issued in 2018 by an international panel of experts in neuromuscular blockade [<a href="#rid3">3</a>], which state that objective monitoring (documentation of TOF ratio [TOFR] ≥0.9) is the only method of assuring satisfactory recovery of neuromuscular function, and if a quantitative monitor is not available, the use of a peripheral nerve stimulator is mandatory when NMBAs are used. Previously, a 2020 guideline for the use of NMBAs from the French anesthesia society recommended monitoring whenever NMBAs are used [<a href="#rid4">4</a>], and the 2021 guidelines for monitoring standards from the Association of Anaesthetists of Great Britain and Ireland (AAGBI) states that quantitative neuromuscular monitoring should be used whenever NMBAs are administered for anesthesia [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Avoidance of residual neuromuscular blockade'</a>.)</p><p>However, in a large 2010 survey of anesthesia providers, 19.3 percent of Europeans and 9.4 percent of Americans never use neuromuscular monitors [<a href="#rid6">6</a>]. In a 2017 survey of anesthesia clinicians in Denmark, objective neuromuscular monitors were always used by 60 percent of clinicians when NMBAs were administered [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H221727416"><span class="h1">CLINICAL EVALUATION</span><span class="headingEndMark"> — </span>Clinical tests that have historically been used to assess recovery from neuromuscular blockade (ie, grip strength, vital capacity, head lift) <strong>are not sensitive or specific for detection of residual weakness </strong>[<a href="#rid8">8-12</a>]. Reliance on clinical evaluation alone to manage neuromuscular blocking agent (NMBA) administration can result in residual paralysis. (See  <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Avoidance of residual neuromuscular blockade'</a>.)</p><p class="headingAnchor" id="H1547568444"><span class="h1">PERIPHERAL NERVE STIMULATION</span><span class="headingEndMark"> — </span>Monitors of neuromuscular function use stimulation of a peripheral nerve, and evaluation of a response (ie, a contraction or twitch) in the innervated muscle. The peripheral nerve stimulator consists of a battery powered device that may be portable or handheld, or mounted to the anesthesia workstation. Stimulator wires are connected to surface electrodes placed on the skin along the course of a peripheral nerve, optimally positioned to avoid direct stimulation of the muscle being monitored. The negative electrode is placed distally and the positive electrode proximally to ensure most effective neurostimulation [<a href="#rid13">13,14</a>].</p><p class="headingAnchor" id="H3515857479"><span class="h2">Nerves that may be monitored</span><span class="headingEndMark"> — </span>Several sites are commonly used for neuromuscular monitoring during administration of neuromuscular blocking agents (NMBAs). Response to stimulation varies among different muscles at the same level of neuromuscular block. (See <a class="local">'Differential muscle sensitivity'</a> below.)</p><p class="headingAnchor" id="H4031965297"><span class="h3">Ulnar nerve</span><span class="headingEndMark"> — </span>The ulnar nerve is the preferred site for peripheral nerve stimulation since it is generally readily accessible and the results are not confounded by direct muscle stimulation: a single ulnar nerve branch crosses over to the radial side of the hand and innervates the adductor pollicis (AP) muscle. The response is assessed at the AP muscle by monitoring adduction of the thumb. Maximal neuronal stimulation and muscular response are achieved by placing the negative electrode one centimeter proximal to the wrist crease, with the positive electrode four to five centimeters proximally along the ulnar surface of the volar forearm  (<a class="graphic graphic_figure graphicRef114145" href="/z/d/graphic/114145.html" rel="external">figure 1</a>) [<a href="#rid13">13</a>]. The abductor digiti minimi (ADM) can also be monitored when stimulating the ulnar nerve, but such monitoring is generally reserved for electromyographic (EMG) monitoring. (See <a class="local">'Electromyography (EMG)'</a> below.)</p><p class="headingAnchor" id="H4161247922"><span class="h3">Facial nerve</span><span class="headingEndMark"> — </span>Facial nerve stimulation is less accurate than ulnar nerve stimulation but may be necessary if surgical positioning limits access to the hands or feet (eg, with the patient's arms tucked at the sides under surgical drapes during laparoscopic pelvic surgery). In one prospective cohort study, 150 patients who received NMBAs during anesthesia were assessed for residual paralysis using acceleromyography in the post anesthesia care unit [<a href="#rid15">15</a>]. Fifty-two percent of patients who were subjectively monitored with facial nerve stimulation had residual paralysis (ie, train-of-four [TOF] ratio &lt;90 percent), compared with 22 percent of patients who had subjective ulnar nerve monitoring. If facial nerve monitoring is used during surgery, ulnar nerve stimulation should be used to confirm adequate reversal of neuromuscular block before extubation, preferably by objective means. (See <a class="local">'Differential muscle sensitivity'</a> below.)</p><p>Facial nerve electrodes are placed on the mastoid process and just anterior to the tragus of the ear, to minimize the risk of direct muscle stimulation  (<a class="graphic graphic_figure graphicRef114147" href="/z/d/graphic/114147.html" rel="external">figure 2</a>) [<a href="#rid16">16</a>]. Both electrodes can also be placed anterior to the ear, along the course of the facial nerve. Contraction of the orbicularis oculi (at the eyelid) or the corrugator supercilii muscle (at the eyebrow) is subjectively assessed by palpation (or visually) in response to stimulation. Acceleromyographic (quantitative) monitoring is possible (and recommended) at both corrugator supercilii and orbicularis oculi muscles  (<a class="graphic graphic_figure graphicRef128514" href="/z/d/graphic/128514.html" rel="external">figure 3</a>) [<a href="#rid17">17</a>]. (See <a class="local">'Acceleromyography (AMG)'</a> below.)</p><p>Importantly, during recovery from neuromuscular block, recovery of the stimulation response at the muscles around the eye may not reflect a degree of recovery in other muscles that would allow safe extubation. (See <a class="local">'Differential muscle sensitivity'</a> below.)</p><p class="headingAnchor" id="H810672869"><span class="h3">Posterior tibial nerve</span><span class="headingEndMark"> — </span>The posterior tibial nerve can be stimulated by placing electrodes superior to the medial malleolus and monitoring the response (flexion) of the great toe  (<a class="graphic graphic_figure graphicRef114146" href="/z/d/graphic/114146.html" rel="external">figure 4</a>).</p><p></p><p class="headingAnchor" id="H959224102"><span class="h3">Paralyzed limb</span><span class="headingEndMark"> — </span>Neuromuscular monitoring should not be performed on a paralyzed limb. Upregulation of acetylcholine receptors after denervation results in resistance to nondepolarizing NMBAs, and variable exaggeration of the TOF ratio (TOFR) in paretic limbs [<a href="#rid18">18,19</a>]. Thus, the degree of systemic neuromuscular block may be underestimated if a paretic limb is monitored.</p><p class="headingAnchor" id="H3635433478"><span class="h2">Patterns of stimulation</span><span class="headingEndMark"> — </span>A variety of patterns of neurostimulation may be used to monitor the degree of neuromuscular blockade. The most commonly used stimulation patterns are the TOF, tetanus, and post-tetanic count.</p><p>Responses to patterns of stimulation differ between depolarizing and nondepolarizing block.</p><p class="headingAnchor" id="H2854521310"><span class="h3">Single twitch</span><span class="headingEndMark"> — </span>Single-twitch (ST) stimulation involves one supramaximal neurostimulation every 10 seconds  (<a class="graphic graphic_figure graphicRef120555" href="/z/d/graphic/120555.html" rel="external">figure 5</a>). ST stimulation is used to determine the potency of NMBAs and is not used clinically.</p><p class="headingAnchor" id="H1932544448"><span class="h3">Train-of-four</span><span class="headingEndMark"> — </span>TOF stimulation consists of four successive supramaximal stimuli delivered at 2 Hz, no less than 10 seconds apart  (<a class="graphic graphic_figure graphicRef120570" href="/z/d/graphic/120570.html" rel="external">figure 6</a>). After administration of a nondepolarizing NMBA, responses at this frequency show fade, or progressively decreasing amplitude of the responses  (<a class="graphic graphic_figure graphicRef120570" href="/z/d/graphic/120570.html" rel="external">figure 6</a>). A TOFR is calculated by dividing the amplitude of the fourth response by the amplitude of the first response, and requires an objective measure of the response to stimulation.</p><p>With progressive nondepolarizing block, the fourth twitch disappears, followed by the third, then the second, and finally the first  (<a class="graphic graphic_figure graphicRef120570" href="/z/d/graphic/120570.html" rel="external">figure 6</a>). As neuromuscular block dissipates, the TOF twitches reappear one by one, with the degree of fade decreasing as full neuromuscular function returns. The TOF count (TOFC) is defined as the number of detectable evoked responses, and it correlates with the degree of neuromuscular block, as follows [<a href="#rid20">20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>TOFC = 1 : &gt;95 percent of nicotinic acetylcholine receptors (nAChRs) blocked</p><p class="bulletIndent1"><span class="glyph">●</span>TOFC = 2 : 85 to 90 percent of nAChRs blocked</p><p class="bulletIndent1"><span class="glyph">●</span>TOFC = 3 : 80 to 85 percent of nAChRs blocked</p><p class="bulletIndent1"><span class="glyph">●</span>TOFC = 4 : 70 to 75 percent of nAChRs blocked</p><p></p><p>With depolarizing block, fade does not occur, and all four twitches decline in amplitude to a similar extent  (<a class="graphic graphic_figure graphicRef120570" href="/z/d/graphic/120570.html" rel="external">figure 6</a>), unless phase II block occurs. Fade in response to TOF stimulation or tetanus, and post-tetanic potentiation, are signs of development of depolarizing phase II block. (See  <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Phase II block'</a>.)</p><p>Depth of block and the use of TOF stimulation during endotracheal intubation, maintenance of anesthesia, and reversal of NMBAs is discussed below and in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia"</a> and <a class="local">'Differential muscle sensitivity'</a> below.)</p><p class="headingAnchor" id="H2773658889"><span class="h3">Tetanus</span><span class="headingEndMark"> — </span>Tetanic stimulation, also called tetanus, involves repetitive stimulation at a frequency of &gt;30 Hz for 5 seconds, which causes sustained muscle contraction  (<a class="graphic graphic_figure graphicRef120571" href="/z/d/graphic/120571.html" rel="external">figure 7</a>). Tetanic contraction fades as the level of nondepolarizing NMBA-induced blockade increases  (<a class="graphic graphic_figure graphicRef120573" href="/z/d/graphic/120573.html" rel="external">figure 8</a> and <a class="graphic graphic_figure graphicRef120574" href="/z/d/graphic/120574.html" rel="external">figure 9</a>), and the degree of fade is equivalent to the fade with TOF stimulation.</p><p>Tetanus should be performed at a frequency below approximately 60 Hz, which is the frequency at which voluntary muscle contraction occurs. At a supraphysiologic frequency, tetanic fade may occur even in the absence of NMBA [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H930783198"><span class="h3">Post-tetanic potentiation</span><span class="headingEndMark"> — </span>Post-tetanic count (PTC) consists of a five-second tetanic (50 Hz) stimulus, followed by a series of ST stimuli delivered at 1 Hz for 20 seconds. Tetanus transiently mobilizes presynaptic acetylcholine (Ach) release into the neuromuscular junction, and therefore the response to subsequent stimulation is potentiated  (<a class="graphic graphic_figure graphicRef120573" href="/z/d/graphic/120573.html" rel="external">figure 8</a>).</p><p>This pattern is useful during deep levels of nondepolarizing neuromuscular block with a TOFC of zero. If PTC is 1, spontaneous recovery from intermediate-acting NMBAs to a TOFC of 1 can take up to 30 minutes [<a href="#rid22">22</a>].</p><p>The TOF count and ratio, and apparent recovery from neuromuscular block, are increased for a variable period of time after tetanus [<a href="#rid23">23,24</a>]. Thus, TOF monitoring at the same site after tetanic stimulation may lead to either unnecessary intraoperative administration of additional NMBA, or overestimation of the degree of recovery at the end of surgery. As such, we suggest waiting two to three minutes after tetanic stimulation before resuming TOF monitoring. Assessing the response to tetanic stimulation during moderate levels of block (when TOFC is 1 to 3) yields no useful information and should not be used.</p><p class="headingAnchor" id="H1178083623"><span class="h3">Double burst stimulation</span><span class="headingEndMark"> — </span>Double-burst stimulation was developed because the assessment of two, instead of four, stimuli might allow more accurate subjective assessment of fade. The two mini-tetanic bursts are delivered 0.75 seconds apart. As in TOFR, the ratio is determined by comparing the second muscle response to the first  (<a class="graphic graphic_figure graphicRef120574" href="/z/d/graphic/120574.html" rel="external">figure 9</a>). In awake patients, it is less painful than tetanic stimulation [<a href="#rid25">25</a>] but it is more painful than TOF. When objective monitoring is used, it offers no advantage over the more widely used TOF pattern.</p><p class="headingAnchor" id="H1538786053"><span class="h1">QUALITATIVE VERSUS QUANTITATIVE MONITORING</span></p><p class="bulletIndent1"><span class="glyph">●</span>Qualitative monitoring refers to visual or tactile (ie, holding the patient's thumb and feeling movement) evaluation of the train-of-four count (TOFC) or degree of train-of-four (TOF) fade in response to neurostimulation provided by a peripheral nerve stimulator  (<a class="graphic graphic_figure graphicRef114145" href="/z/d/graphic/114145.html" rel="external">figure 1</a>). Qualitative monitoring is sometimes referred to as subjective monitoring.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Quantitative, or objective, monitors actually measure the response of the muscle to the neurostimulation, and should be used whenever they are available. (See <a class="local">'Quantitative monitoring'</a> below.)</p><p></p><p>Assessment of the degree of neuromuscular block using qualitative evaluation is less accurate than quantitative evaluation, both when assessing the TOFC and TOF ratio (TOFR). Thus, qualitative evaluation with a peripheral nerve stimulator may provide inaccurate information regarding the level of blockade, which may have implications for the dose and type or reversal agent used, as well as the timing of tracheal extubation. If a quantitative monitor is not available, qualitative monitoring with a peripheral nerve stimulator should be used, recognizing the limitations of subjective assessment. Suggested management according to monitoring and a comparison of the depth of block based on quantitative and qualitative monitoring are included in tables  (<a class="graphic graphic_table graphicRef114083" href="/z/d/graphic/114083.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef114082" href="/z/d/graphic/114082.html" rel="external">table 3</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessing TOFC </strong>–<strong> </strong>Clinicians tend to overestimate the TOFC when using subjective evaluation, especially at moderate levels of block. This has been demonstrated for both accelerometry (AMG) and for electromyography (EMG) monitoring.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In one study including 90 patients who were recovering from an intubating dose of <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">rocuronium</a> or <a class="drug drug_general" data-topicid="10041" href="/z/d/drug information/10041.html" rel="external">vecuronium</a>, the TOFC was assessed subjectively by clinicians and simultaneously with AMG [<a href="#rid26">26</a>]. The TOFC was the same in 36 percent of measurements at a TOFC of 1 to 3, and 87 percent at TOFC of 0 or 4; 96 percent of disagreements were overestimates using subjective assessment.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a single-institution study of 50 patients who were simultaneously monitored with subjective assessment and with EMG during nondepolarizing neuromuscular block, subjective evaluation overestimated the degree of recovery 47 percent of the time, compared with EMG assessment [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessing fade </strong>–<strong> </strong>Similarly, the level of fade is difficult to detect subjectively, with most clinicians unable to detect fade when TOFR &gt;0.4 [<a href="#rid28">28-31</a>]. Multiple studies have reported residual neuromuscular block (ie, TOFR &lt;0.9 measured by quantitative monitors) despite the use of subjective monitoring with a peripheral nerve stimulator [<a href="#rid27">27,32</a>]. (See  <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Avoidance of residual neuromuscular blockade'</a>.)</p><p></p><p>A 2020 meta-analysis of 53 observational and randomized trials found that for patients who received intermediate-acting NMBAs (ie, <a class="drug drug_general" data-topicid="8973" href="/z/d/drug information/8973.html" rel="external">atracurium</a>, <a class="drug drug_general" data-topicid="9270" href="/z/d/drug information/9270.html" rel="external">cisatracurium</a>, mivacurium, <a class="drug drug_general" data-topicid="10041" href="/z/d/drug information/10041.html" rel="external">vecuronium</a>, or <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">rocuronium</a>), the use of quantitative neuromuscular monitoring was associated with a reduced incidence of postoperative residual neuromuscular block, compared with qualitative (subjective) monitoring, or no monitoring at all (11.5 versus 30.6 versus 33.1 percent, respectively) [<a href="#rid33">33</a>]. However, the quality of the data was judged to be very low.</p><p class="headingAnchor" id="H3417565282"><span class="h1">QUANTITATIVE MONITORING</span></p><p class="headingAnchor" id="H1068000675"><span class="h2">Types of quantitative monitors</span><span class="headingEndMark"> — </span>Several types of quantitative neuromuscular monitors are available, and they are categorized by the method they use to obtain quantitative measurements (ie, the monitoring modality). Some monitors are handheld, portable devices, whereas others are fixed devices integrated into the anesthesia work station. Available monitors use electromyography (EMG), acceleromyography (AMG), or less commonly, kinemyography (KMG). In research settings, mechanomyography has been used in the past and was the standard for comparison of new devices, but it cannot be used clinically and the devices are no longer manufactured.</p><p class="headingAnchor" id="H263578811"><span class="h2">Choice of quantitative monitor</span><span class="headingEndMark"> — </span>When an EMG monitor is available, we suggest using EMG rather than AMG or KMG. Relative advantages of EMG include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>EMG monitors do not require unrestricted movement of the stimulated muscle. This is important because increasingly the arms are tucked at the patient's side during surgery, such that AMG or KMG cannot be used without a special device protecting the hand.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Unlike AMG, EMG is not subject to reverse fade, so that baseline TOFR is typically approximately 1.0 with EMG monitoring. Thus, normalization of the TOFR is not required when assessing block reversal with EMG. Reverse fade and normalization are described below. (See <a class="local">'Acceleromyography (AMG)'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>EMG monitors have a high level of agreement with mechanomyography [<a href="#rid34">34</a>], and better agreement than AMG [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>EMG monitors are better indicators of adequate recovery than AMG, as a result of greater precision and repeatability [<a href="#rid36">36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Measurements obtained with EMG and AMG devices are not entirely interchangeable. In a single-center study of 36 patients, AMG and EMG measurements agreed on the level of neuromuscular blockade 73 percent of the time [<a href="#rid37">37</a>]. AMG frequently measured higher post-tetanic counts than EMG during deep blockade. Similarly, another single study of 50 patients having EMG and AMG performed simultaneously on the same limb demonstrated greater variability with AMG than EMG at baseline and during recovery [<a href="#rid36">36</a>].</p><p></p><p>Relative disadvantages of EMG monitors are that they may be affected by electrical interference in the operating room (eg, electrocautery), which is not a problem with AMG or KMG, and they require manufacturer-specific electrode strips, which are significantly more expensive than the standard ECG electrodes used for AMG and KMG.</p><p class="headingAnchor" id="H131683014"><span class="h2">Electromyography (EMG)</span><span class="headingEndMark"> — </span>EMG monitors use stimulating skin surface electrodes to generate an action potential of the target peripheral nerve, and then measure the evoked muscle response (action potential). These monitors do not require the needle electrodes that are usually used for EMG performed for diagnosis of neurologic disease or intraoperative neuromonitoring. (See  <a class="medical medical_review" href="/z/d/html/91216.html" rel="external">"Neuromonitoring in surgery and anesthesia", section on 'Electromyography'</a>.)</p><p>For monitoring neuromuscular blockade, EMG electrodes are typically placed over the ulnar nerve, after which the muscle response is measured at the adductor pollicis, abductor digiti minimi, or first dorsal interosseus muscle  (<a class="graphic graphic_picture graphicRef131801" href="/z/d/graphic/131801.html" rel="external">picture 1</a>). EMG monitors can use the same patterns of stimulation described above, and report a train-of-four (TOF) count and ratio.</p><p>One benefit of EMG monitors is that they do not require unrestricted motion of the hand and therefore can be used when the arms are tucked at the patient's side. When recorded simultaneously, TOF ratios (TOFR) are higher with AMG monitoring than with EMG monitoring; however, recovery is still defined by a TOFR &gt;0.9 as measured at the adductor pollicis with either modality [<a href="#rid38">38</a>]. Unlike AMG, EMG monitoring is not associated with the "reverse fade," phenomenon. and there is a high level of agreement between newer EMG devices and newer AMG devices [<a href="#rid39">39</a>]. Given its high level of agreement with mechanomyography (the traditional gold standard for objective monitoring) and utility when the limbs are restricted, many experts feel EMG has become the new gold standard for objective monitoring [<a href="#rid40">40,41</a>].</p><p>There are several standalone handheld EMG monitors available (eg, TetraGraph, Twitchview) as well as a monitor that is incorporated into the anesthesia workstation. The E-NMI device is a component of the General Electric Datex-Ohmeda workstation.</p><p class="headingAnchor" id="H1659726355"><span class="h2">Acceleromyography (AMG)</span><span class="headingEndMark"> — </span>For AMG using the adductor pollicis muscle (APM), skin surface electrodes are placed over the ulnar nerve, and an accelerometer mounted to the thumb measures acceleration in response to ulnar nerve stimulation. This technique is based on the Newton's Second Law of Motion (ie, force = mass x acceleration), such that the force exerted by the thumb is proportional to measured acceleration, since mass doesn't change. The monitor displays a TOF count (TOFC), and when there are four twitches, a TOFR. For AMG the arm position must stay the same throughout the monitoring period, and the thumb must be free to move, unimpeded by surgical drapes or positioning. Therefore, AMG cannot be applied to an arm that is tucked at the patient's side, unless the arm is placed in a special protective device  (<a class="graphic graphic_picture graphicRef131800" href="/z/d/graphic/131800.html" rel="external">picture 2</a>).</p><p>Following induction of general anesthesia, the AMG device should optimally be calibrated and a baseline TOFR established <strong>prior</strong> to administration of NMBA.</p><p class="bulletIndent1"><span class="glyph">●</span>Calibration refers to a process the device performs to determine the optimal current that will achieve supramaximal stimulation, independent of the monitoring modality. During calibration, the device delivers increasing current in 10 mA increments and sets the stimulation at 10 mA above that which achieves maximal stimulation. If calibration is not performed, most monitors default to a current of 50 to 60 mA.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Establishing a baseline TOFR is necessary for accurately interpreting data from AMG monitors, particularly when assessing recovery from neuromuscular block. The baseline TOFR in the absence of neuromuscular blockade measured by AMG at the adductor pollicis muscle is often &gt;1.0 (&gt;100 percent), and may be as high as approximately 1.5 [<a href="#rid42">42</a>]. Thus, when assessing the degree of reversal, the goal should be achieving a TOFR ≥0.9 times baseline rather than an absolute value of 0.9. Correction for the baseline TOFR is called normalization. For example, if the baseline TOFR before administration of NMBA is 1.2, the normalized value when assessing for safe recovery would be 0.9 x 1.2 = 1.08. If the TOFR of 0.9 is used in this circumstance, the patient's normalized recovery value would be 0.9 / 1.2 = 0.75, which would not indicate adequate recovery for extubation.</p><p></p><p class="bulletIndent1">The effect by which the TOFR exceeds 1.0 by accelerometry is called the reverse fade phenomenon; its mechanism has not been elucidated. To address this phenomenon, some monitors default to displaying the ratio of the fourth twitch to the second (T4/T2), and others report a baseline numerical value of 100 percent for any value ≥100 (though the raw data is displayed on a bar graph) [<a href="#rid43">43</a>]. Whereas the monitor using T4/T2 rather than T4/T1 may affect the conduct of research involving neuromuscular blockade, this is unlikely to be a relevant issue when these devices are used clinically.</p><p></p><p>The early versions of AMG transducers measured acceleration in one plane of motion (TOF-Watch, TOF-Watchs S, TOF-Watch SX), and are no longer commercially available. Newer AMG monitors (eg, TOFScan, StimPOD) use three dimensional transducers that were developed to account for the complex motion of muscles in response to neurostimulation and have demonstrated good agreement with mechanomyography and normalized single plane accelerometers [<a href="#rid44">44</a>]. Per the manufacturer's directions, calibration is unnecessary for the TOFScan as the device defaults to 50 mA output. Normalization is not performed since the device limits the numerical display of the TOFR to ≤1.0. The TOFScan device includes a hand adapter that stabilizes the position of the thumb and is embedded with the accelerometry sensor. In addition to its 3D transducer, the StimPOD device has both AMG and EMG capabilities.</p><p class="headingAnchor" id="H4113752610"><span class="h2">Kinemyography (KMG)</span><span class="headingEndMark"> — </span>KMG measures the electrical signal generated from the distortion (bending) of a mechanosensor that is placed at the base of the thumb and index finger. KMG results are not interchangeable with other quantitative modalities, and the technology has similar limitations as AMG, being dependent on freely moving muscles [<a href="#rid45">45</a>]. However, KMG is an easy to use modality and is a much more reliable monitor than subjective assessment with a peripheral nerve stimulator. A KMG device is available on General Electric anesthesia machines.</p><p class="headingAnchor" id="H2354442800"><span class="h1">DIFFERENTIAL MUSCLE SENSITIVITY</span><span class="headingEndMark"> — </span>Muscle groups respond differently to neuromuscular blocking agents (NMBAs), such that the monitored twitch response may not accurately reflect neuromuscular transmission in clinically important muscles (eg, airway muscles and diaphragm)  (<a class="graphic graphic_table graphicRef114082" href="/z/d/graphic/114082.html" rel="external">table 3</a> and <a class="graphic graphic_figure graphicRef115809" href="/z/d/graphic/115809.html" rel="external">figure 10</a>). After NMBA administration, neuromuscular block occurs faster in central muscles (eg, larynx and diaphragm) than peripheral muscles (adductor pollicis, flexor hallucis) [<a href="#rid46">46-50</a>], because of greater blood flow and drug delivery to the central muscles. However, the diaphragm is also more resistant to the effects of nondepolarizing NMBAs, and recovers faster, because it has a higher density of nAChRs [<a href="#rid51">51</a>].</p><p>The response to stimulation at the corrugator supercilii muscle (at the eyebrow) correlates closely with neuromuscular block at the diaphragm and larynx [<a href="#rid17">17,48</a>], whereas stimulation at the orbicularis oculi correlates closely with the adductor pollicis muscle [<a href="#rid17">17</a>]. However, in practice it is difficult to separate the responses of these two muscles, and therefore facial nerve stimulation may overestimate the degree of recovery from neuromuscular block [<a href="#rid15">15</a>].</p><p>The sequence of recovery of various muscles after nondepolarizing neuromuscular blockade is as follows (fastest to slowest): diaphragm &gt; laryngeal muscles &gt; corrugator supercilii &gt; abdominal muscles &gt; orbicularis oculi &gt; geniohyoid muscle (upper airway) &gt; adductor pollicis muscle  (<a class="graphic graphic_figure graphicRef115809" href="/z/d/graphic/115809.html" rel="external">figure 10</a>) [<a href="#rid17">17,46-49,51</a>].</p><p>The clinical implications of the difference in sensitivity of various muscles include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>During intubation if deep neuromuscular blockade is confirmed by monitoring adductor pollicis or flexor hallucis stimulation, pharyngeal muscles are usually blocked as well, and optimal intubating conditions are achieved.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>During surgery, the absence of a twitch at the adductor pollicis muscle (APM) does not guarantee that the diaphragm will be paralyzed. A post-tetanic count of 1 or 2 at the APM indicates deep block, but diaphragm movement is still possible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>During recovery from neuromuscular block, a train-of-four ratio (TOFR) &gt;0.9 at the APM represents full recovery; the airway muscles and diaphragm have recovered fully.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monitoring facial muscles will overestimate the degree of recovery. If the arms are not accessible due to surgical positioning, monitor the facial muscles but transition to the arms once they become available.</p><p></p><p class="headingAnchor" id="H2050260110"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Quantitative monitoring preferred</strong> – We suggest the use of quantitative, objective measurement of neuromuscular function to monitor administration of and recovery from neuromuscular blocking agents (NMBAs) whenever possible. If a quantitative monitor is not available, a peripheral nerve stimulator may be used with subjective evaluation, recognizing the limitations of the technology  (<a class="graphic graphic_figure graphicRef114145" href="/z/d/graphic/114145.html" rel="external">figure 1</a>). Clinical tests (ie, grip strength, vital capacity, head lift) are not sensitive or specific for detection of residual weakness. (See <a class="local">'When and how to monitor neuromuscular blockade'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peripheral nerve stimulation</strong> – Neuromuscular monitoring for NMBAs most commonly involves the use of a peripheral nerve stimulator, with stimulation of a nerve and assessment of the muscle response.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Monitoring site</strong> – The ulnar nerve is the preferred monitoring site, with response assessed in the adductor pollicis muscle  (<a class="graphic graphic_figure graphicRef114145" href="/z/d/graphic/114145.html" rel="external">figure 1</a>). (See <a class="local">'Peripheral nerve stimulation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Stimulation patterns</strong> – The most commonly used patterns of stimulation include a train-of-four (TOF) stimuli, tetanus, and post-tetanic potentiation. Double burst stimulation may be used as well  (<a class="graphic graphic_table graphicRef114083" href="/z/d/graphic/114083.html" rel="external">table 2</a>). (See <a class="local">'Patterns of stimulation'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>TOF stimulation consists of four successive supramaximal stimuli delivered at 2 Hz, no less than 10 seconds apart  (<a class="graphic graphic_figure graphicRef120570" href="/z/d/graphic/120570.html" rel="external">figure 6</a>). With progressive nondepolarizing block, the amplitude of successive twitches in the TOF decrease, or fade, and ultimately the twitches disappear one by one. The TOF ratio (TOFR) (ie, ratio of the amplitude of the fourth to the first twitch) and the TOF count (TOFC; ie, the number of twitches that occur after TOF stimulation) are used as measures of the degree of nondepolarizing neuromuscular block. With depolarizing block, fade does not occur during TOF stimulation, unless phase II block develops. (See <a class="local">'Train-of-four'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Tetanic stimulation, also called tetanus, involves repetitive stimulation at a frequency of &gt;30 Hz for 5 seconds, which causes sustained muscle contraction. With increasing nondepolarizing block, tetanic contraction fades  (<a class="graphic graphic_figure graphicRef120571" href="/z/d/graphic/120571.html" rel="external">figure 7</a>). (See <a class="local">'Tetanus'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Post-tetanic count (PTC) consists of a five-second tetanic (50 Hz) stimulus, followed by a series of single stimuli delivered at 1 Hz for 20 seconds  (<a class="graphic graphic_figure graphicRef120571" href="/z/d/graphic/120571.html" rel="external">figure 7</a>). Post-tetanic potentiation, or increase in PTC, is a characteristic of nondepolarizing neuromuscular block, and is useful during deep levels of block with a TOFC of zero  (<a class="graphic graphic_figure graphicRef120573" href="/z/d/graphic/120573.html" rel="external">figure 8</a>).</p><p></p><p class="bulletIndent3">The TOFC and TOFR are increased, or potentiated, for a variable period of time after tetanus. Therefore, tetanus should not be used during moderate levels of neuromuscular block (ie, TOFC 1 to 3), and TOF stimulation should not be used for two to three minutes after tetanus, to avoid underestimating the degree of neuromuscular block. (See <a class="local">'Post-tetanic potentiation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Quantitative monitors</strong> – Options for quantitative, objective monitoring include electromyography (EMG), acceleromyography (AMG), and less commonly, kinemyography (KMG). Some experts believe that EMG should be the gold standard for objective intraoperative neuromuscular blockade monitoring, since EMG does not require unrestricted movement of the stimulated muscle, and does not require normalization of the TOFR. (See <a class="local">'Choice of quantitative monitor'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>EMG monitors use stimulating skin surface electrodes to generate an action potential of the target nerve, and then measure the evoked muscle response (action potential)  (<a class="graphic graphic_picture graphicRef131801" href="/z/d/graphic/131801.html" rel="external">picture 1</a>). (See <a class="local">'Electromyography (EMG)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For AMG using the adductor pollicis muscle (APM), skin surface electrodes are placed over the ulnar nerve, and an accelerometer mounted to the thumb measures acceleration in response to ulnar nerve stimulation. The baseline TOFR with an AMG monitor is often &gt;1.0. If so, safe reversal of neuromuscular blockade is ensured by aiming for a normalized TOFR, calculated as ≥90 percent of the baseline TOFR  (<a class="graphic graphic_picture graphicRef131800" href="/z/d/graphic/131800.html" rel="external">picture 2</a>). (See <a class="local">'Acceleromyography (AMG)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential muscle sensitivity</strong> – Differential muscle sensitivity must be recognized when interpreting the results of neuromuscular monitoring  (<a class="graphic graphic_figure graphicRef115809" href="/z/d/graphic/115809.html" rel="external">figure 10</a> and <a class="graphic graphic_table graphicRef114082" href="/z/d/graphic/114082.html" rel="external">table 3</a>). (See <a class="local">'Differential muscle sensitivity'</a> above.)</p><p></p><p class="headingAnchor" id="H1856999034"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Sorin Brull, MD, FCARCSI (Hon), who contributed to earlier versions of this topic review.</p><p>The UpToDate editorial staff also acknowledges Mohamed Naguib, MD, now deceased, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Fuchs-Buder T, Romero CS, Lewald H, et al. Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol 2023; 40:82.</a></li><li><a class="nounderline abstract_t">Thilen SR, Weigel WA, Todd MM, et al. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology 2023; 138:13.</a></li><li><a class="nounderline abstract_t">Naguib M, Brull SJ, Kopman AF, et al. Consensus Statement on Perioperative Use of Neuromuscular Monitoring. Anesth Analg 2018; 127:71.</a></li><li><a class="nounderline abstract_t">Plaud B, Baillard C, Bourgain JL, et al. Guidelines on muscle relaxants and reversal in anaesthesia. Anaesth Crit Care Pain Med 2020; 39:125.</a></li><li><a class="nounderline abstract_t">Klein AA, Meek T, Allcock E, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2021: Guideline from the Association of Anaesthetists. Anaesthesia 2021; 76:1212.</a></li><li><a class="nounderline abstract_t">Naguib M, Kopman AF, Lien CA, et al. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111:110.</a></li><li><a class="nounderline abstract_t">Söderström CM, Eskildsen KZ, Gätke MR, Staehr-Rye AK. Objective neuromuscular monitoring of neuromuscular blockade in Denmark: an online-based survey of current practice. Acta Anaesthesiol Scand 2017; 61:619.</a></li><li><a class="nounderline abstract_t">Eikermann M, Groeben H, Hüsing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98:1333.</a></li><li><a class="nounderline abstract_t">Pedersen T, Viby-Mogensen J, Bang U, et al. Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade? Anesthesiology 1990; 73:835.</a></li><li><a class="nounderline abstract_t">Cammu G, De Witte J, De Veylder J, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg 2006; 102:426.</a></li><li><a class="nounderline abstract_t">Hayes AH, Mirakhur RK, Breslin DS, et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56:312.</a></li><li><a class="nounderline abstract_t">Fruergaard K, Viby-Mogensen J, Berg H, el-Mahdy AM. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Acta Anaesthesiol Scand 1998; 42:1168.</a></li><li><a class="nounderline abstract_t">Brull SJ, Silverman DG. Pulse width, stimulus intensity, electrode placement, and polarity during assessment of neuromuscular block. Anesthesiology 1995; 83:702.</a></li><li><a class="nounderline abstract_t">Brull SJ, Silverman DG. Real time versus slow-motion train-of-four monitoring: a theory to explain the inaccuracy of visual assessment. Anesth Analg 1995; 80:548.</a></li><li><a class="nounderline abstract_t">Thilen SR, Hansen BE, Ramaiah R, et al. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology 2012; 117:964.</a></li><li><a class="nounderline abstract_t">Naguib M, Brull SJ, Johnson KB. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia 2017; 72 Suppl 1:16.</a></li><li><a class="nounderline abstract_t">Plaud B, Debaene B, Donati F. The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles. Anesthesiology 2001; 95:96.</a></li><li><a class="nounderline abstract_t">Moningi S, Durga P, Mantha S, Ramachandra G. Train of four responses in paretic limbs. J Neurosurg Anesthesiol 2009; 21:334.</a></li><li><a class="nounderline abstract_t">Iwasaki H, Namiki A, Omote K, et al. Response differences of paretic and healthy extremities to pancuronium and neostigmine in hemiplegic patients. Anesth Analg 1985; 64:864.</a></li><li><a class="nounderline abstract_t">Lee CM. Train-of-4 quantitation of competitive neuromuscular block. Anesth Analg 1975; 54:649.</a></li><li><a class="nounderline abstract_t">MERTON PA. Voluntary strength and fatigue. J Physiol 1954; 123:553.</a></li><li><a class="nounderline abstract_t">Viby-Mogensen J, Howardy-Hansen P, Chraemmer-Jørgensen B, et al. Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade. Anesthesiology 1981; 55:458.</a></li><li><a class="nounderline abstract_t">Brull SJ, Connelly NR, O'Connor TZ, Silverman DG. Effect of tetanus on subsequent neuromuscular monitoring in patients receiving vecuronium. Anesthesiology 1991; 74:64.</a></li><li><a class="nounderline abstract_t">Brull SJ, Silverman DG. Tetanus-induced changes in apparent recovery after bolus doses of atracurium or vecuronium. Anesthesiology 1992; 77:642.</a></li><li><a class="nounderline abstract_t">Engbaek J, Ostergaard D, Viby-Mogensen J. Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth 1989; 62:274.</a></li><li><a class="nounderline abstract_t">Bhananker SM, Treggiari MM, Sellers BA, et al. Comparison of train-of-four count by anesthesia providers versus TOF-Watch® SX: a prospective cohort study. Can J Anaesth 2015; 62:1089.</a></li><li><a class="nounderline abstract_t">Renew JR, Hernandez-Torres V, Chaves-Cardona H, et al. Comparison of visual and electromyographic assessments with train-of-four stimulation of the ulnar nerve: a prospective cohort study. Can J Anaesth 2023; 70:878.</a></li><li><a class="nounderline abstract_t">Viby-Mogensen J, Jensen NH, Engbaek J, et al. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985; 63:440.</a></li><li><a class="nounderline abstract_t">Brull SJ, Silverman DG. Visual and tactile assessment of neuromuscular fade. Anesth Analg 1993; 77:352.</a></li><li><a class="nounderline abstract_t">Capron F, Fortier LP, Racine S, Donati F. Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-hertz tetanus, 100-hertz tetanus, and acceleromyography. Anesth Analg 2006; 102:1578.</a></li><li><a class="nounderline abstract_t">Drenck NE, Ueda N, Olsen NV, et al. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology 1989; 70:578.</a></li><li><a class="nounderline abstract_t">Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 2007; 98:302.</a></li><li><a class="nounderline abstract_t">Carvalho H, Verdonck M, Cools W, et al. Forty years of neuromuscular monitoring and postoperative residual curarisation: a meta-analysis and evaluation of confidence in network meta-analysis. Br J Anaesth 2020; 125:466.</a></li><li><a class="nounderline abstract_t">Engbaek J, Roed J, Hangaard N, Viby-Mogensen J. The agreement between adductor pollicis mechanomyogram and first dorsal interosseous electromyogram. A pharmacodynamic study of rocuronium and vecuronium. Acta Anaesthesiol Scand 1994; 38:869.</a></li><li><a class="nounderline abstract_t">Bowdle A, Bussey L, Michaelsen K, et al. A comparison of a prototype electromyograph vs. a mechanomyograph and an acceleromyograph for assessment of neuromuscular blockade. Anaesthesia 2020; 75:187.</a></li><li><a class="nounderline abstract_t">Nemes R, Lengyel S, Nagy G, et al. Ipsilateral and Simultaneous Comparison of Responses from Acceleromyography- and Electromyography-based Neuromuscular Monitors. Anesthesiology 2021; 135:597.</a></li><li><a class="nounderline abstract_t">Joo H, Cho S, Lee JW, et al. Comparison of Contralateral Acceleromyography and Electromyography for Posttetanic Count Measurement. Anesthesiology 2023; 138:241.</a></li><li><a class="nounderline abstract_t">Kopman AF, Chin W, Cyriac J. Acceleromyography vs. electromyography: an ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation. Acta Anaesthesiol Scand 2005; 49:316.</a></li><li><a class="nounderline abstract_t">Renew JR, Hernandez-Torres V, Logvinov I, et al. Comparison of the TetraGraph and TOFscan for monitoring recovery from neuromuscular blockade in the Post Anesthesia Care Unit. J Clin Anesth 2021; 71:110234.</a></li><li><a class="nounderline abstract_t">Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111:129.</a></li><li><a class="nounderline abstract_t">Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789.</a></li><li><a class="nounderline abstract_t">Suzuki T, Fukano N, Kitajima O, et al. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block. Br J Anaesth 2006; 96:44.</a></li><li><a class="nounderline abstract_t">Kopman AF, Kopman DJ. An analysis of the TOF-watch algorithm for modifying the displayed train-of-four ratio. Acta Anaesthesiol Scand 2006; 50:1313.</a></li><li><a class="nounderline abstract_t">Murphy GS, Szokol JW, Avram MJ, et al. Comparison of the TOFscan and the TOF-Watch SX during Recovery of Neuromuscular Function. Anesthesiology 2018; 129:880.</a></li><li><a class="nounderline abstract_t">Stewart PA, Freelander N, Liang S, et al. Comparison of electromyography and kinemyography during recovery from non-depolarising neuromuscular blockade. Anaesth Intensive Care 2014; 42:378.</a></li><li><a class="nounderline abstract_t">Wright PM, Caldwell JE, Miller RD. Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans. Anesthesiology 1994; 81:1110.</a></li><li><a class="nounderline abstract_t">Meistelman C, Plaud B, Donati F. Neuromuscular effects of succinylcholine on the vocal cords and adductor pollicis muscles. Anesth Analg 1991; 73:278.</a></li><li><a class="nounderline abstract_t">Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology 1991; 74:833.</a></li><li><a class="nounderline abstract_t">Hemmerling TM, Schmidt J, Hanusa C, et al. Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth 2000; 85:856.</a></li><li><a class="nounderline abstract_t">Sopher MJ, Sears DH, Walts LF. Neuromuscular function monitoring comparing the flexor hallucis brevis and adductor pollicis muscles. Anesthesiology 1988; 69:129.</a></li><li><a class="nounderline abstract_t">Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. Anesthesiology 1990; 73:870.</a></li></ol></div><div id="topicVersionRevision">Topic 114324 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36377554" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36520073" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29200077" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Consensus Statement on Perioperative Use of Neuromuscular Monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31926308" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Guidelines on muscle relaxants and reversal in anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34013531" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Recommendations for standards of monitoring during anaesthesia and recovery 2021: Guideline from the Association of Anaesthetists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19910616" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A survey of current management of neuromuscular block in the United States and Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28573656" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Objective neuromuscular monitoring of neuromuscular blockade in Denmark: an online-based survey of current practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12766640" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1978613" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16428537" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Postoperative residual paralysis in outpatients versus inpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11284816" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Postoperative residual block after intermediate-acting neuromuscular blocking drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9834799" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7574049" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pulse width, stimulus intensity, electrode placement, and polarity during assessment of neuromuscular block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7864423" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Real time versus slow-motion train-of-four monitoring: a theory to explain the inaccuracy of visual assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23001053" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Intraoperative neuromuscular monitoring site and residual paralysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28044330" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Conceptual and technical insights into the basis of neuromuscular monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11465590" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19955896" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Train of four responses in paretic limbs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4025852" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Response differences of paretic and healthy extremities to pancuronium and neostigmine in hemiplegic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1237253" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Train-of-4 quantitation of competitive neuromuscular block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13152698" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Voluntary strength and fatigue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7294384" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1670914" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Effect of tetanus on subsequent neuromuscular monitoring in patients receiving vecuronium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1358004" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Tetanus-induced changes in apparent recovery after bolus doses of atracurium or vecuronium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2522790" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26224034" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Comparison of train-of-four count by anesthesia providers versus TOF-Watch®SX: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36991299" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Comparison of visual and electromyographic assessments with train-of-four stimulation of the ulnar nerve: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4037404" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Tactile and visual evaluation of the response to train-of-four nerve stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8394051" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Visual and tactile assessment of neuromuscular fade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16632846" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-hertz tetanus, 100-hertz tetanus, and acceleromyography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2929994" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17307778" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32680607" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Forty years of neuromuscular monitoring and postoperative residual curarisation: a meta-analysis and evaluation of confidence in network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7887113" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The agreement between adductor pollicis mechanomyogram and first dorsal interosseous electromyogram. A pharmacodynamic study of rocuronium and vecuronium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31617199" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A comparison of a prototype electromyograph vs. a mechanomyograph and an acceleromyograph for assessment of neuromuscular blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34329371" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Ipsilateral and Simultaneous Comparison of Responses from Acceleromyography- and Electromyography-based Neuromuscular Monitors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36520831" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Comparison of Contralateral Acceleromyography and Electromyography for Posttetanic Count Measurement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15752395" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Acceleromyography vs. electromyography: an ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33677425" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Comparison of the TetraGraph and TOFscan for monitoring recovery from neuromuscular blockade in the Post Anesthesia Care Unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20442261" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17635389" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16299046" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17067341" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : An analysis of the TOF-watch algorithm for modifying the displayed train-of-four ratio.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30130260" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Comparison of the TOFscan and the TOF-Watch SX during Recovery of Neuromuscular Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24794479" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Comparison of electromyography and kinemyography during recovery from non-depolarising neuromuscular blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7978469" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1867420" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Neuromuscular effects of succinylcholine on the vocal cords and adductor pollicis muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1673592" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11732519" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3389551" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Neuromuscular function monitoring comparing the flexor hallucis brevis and adductor pollicis muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1978614" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
